ArticleScience (New York, N.Y.)2025

Divergent FOXA1 mutations drive prostate tumorigenesis and therapy-resistant cellular plasticity.

Sanjana Eyunni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.